SkinHealth Q1 revenue $64.9M, adjusted EBITDA $8.5M; cuts FY revenue outlook

SkinHealth Systems Inc.

2026-Q1 EPS reported -$0.05 vs consensus -$0.08 ▲ beat (+36.5%)

Net sales $64.9M (-6.8% YoY); net loss improved to ($6.6M) from ($10.1M).
Adjusted EBITDA $8.5M, margin 13.1% vs 10.4% YoY; gross margin 68.5% vs 69.8%.
Delivery systems sold 746 (down 13.5% YoY); active install base grew to 36,419.
CEO Pedro Malha cited market challenges and lowered full-year revenue outlook.
Adjusted gross margin improved to 72.2% from 71.9% on cost discipline.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

SkinHealth Systems Inc. updated its first quarter ended March 31, 2026 guidance (lowered).

Period: first quarter ended March 31, 2026
Guidance: lowered
Result: preliminary results

Exact text from the filing

On May 7, 2026, SkinHealth Systems Inc. (the “Company”) issued a press release and will hold a conference call regarding its financial results for its fiscal quarter ended March 31, 2026.

View on SEC.gov

Browse all earnings releases →

SkinHealth Systems Inc. filing history →

Source: SEC EDGAR

accession 0001628280-26-032099

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.